Guest: Marie-Claire Rowlinson, PhD, D(ABMM) The COVID-19 pandemic has pushed clinical laboratories to find new strategies to keep at-risk patients protected. When it comes to tuberculosis testing, what are some things laboratories are doing to ensure patient safety? Dr. Marie-Claire Rowlinson details some of these safety measures and discusses the pandemic’s impact on laboratory testing.

Tackling TB

Tuberculosis Screening in At-Risk Patients During the COVID-19 Pandemic

Although we may not see tuberculosis cases too often, that doesn’t mean this disease isn’t out there. In fact, up to 13 million people are carrying the latent infection, which can asymptomatically exist in a patient for years and can be fatal if it isn’t caught early enough. That’s why knowing which of our patients are at risk and using effective screening measures are now more critical than ever. In the hopes of eradicating this disease once and for all, Tackling TB brings together experts in the areas of public health and infectious disease to discuss current guideline recommendations, testing methodologies, and the importance of primary care physicians in conducting risk-based screening protocols. In collaboration with:

About

Tackling TB